XML 70 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Reverse takeover transaction with NCAC - listing expenses (Details)
 12 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Jan. 26, 2024
$ / shares
Jan. 25, 2024
$ / shares
Mar. 31, 2023
USD ($)
Mar. 31, 2023
CAD ($)
Mar. 31, 2022
USD ($)
Consideration paid:            
Shares issued to NCAC shareholders | shares 150,000          
Fair value of the common shares | $ / shares     $ 4.79      
Net identifiable liabilities acquired:            
Cash and cash equivalents $ 733,188     $ 1,334,280 $ 1,334,280 $ 1,753,437
Accounts payable and accrued liabilities (755,202)     $ (1,790,700) $ (1,790,700) $ (131,642)
Derivative warrant liabilities (Note 10) (901,608)          
Listing Expense $ 41,481,605          
NCAC            
Consideration paid:            
Shares issued to NCAC shareholders | shares 7,794,659          
Total consideration shares issued | shares 7,794,659          
Fair value of the common shares | $ / shares $ 4.79 $ 3.55 $ 4.79      
Deemed consideration amount for the common shares issued $ 37,336,416          
Net identifiable liabilities acquired:            
Cash and cash equivalents 203          
Accounts payable and accrued liabilities (2,136,505)          
NCAC promissory note (Note 11) (1,413,529)          
Derivative warrant liabilities (Note 10) (595,358)          
Net liabilities acquired 4,145,189          
Listing Expense $ 41,481,605